feed,title,long_url,short_url
Investors,Rapt Therapeutics Crashes 65% After Unexpected Liver Failure Sidelines Two Tests,https://www.investors.com/news/technology/biotech-stock-rapt-crashes-to-record-low-after-side-effect-sidelines-two-clinical-studies/,https://da.gd/uUeV
